View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

The Conferences Forum Launches Patients as Partners Event


  • November 27, 2013

  • Patients as Partners (March 3-4, 2014, Philadelphia) takes a comprehensive view of the patient experience and how we engage with patients across the entire clinical trial continuum. This includes early research, patient-centric protocol design, recruitment, retention, engagement, and communicating results with patients acting as ambassadors and educators.

    The Conference Forum is proud to present Patients as Partners with CISCRP’s founder Ken Getz as conference chair, along with an exciting speaking faculty representing industry, advocacy, academia, patients and the FDA. Together, they address the latest strategies, technologies and policies to vastly improve the patient experience in clinical trials. The conference addresses how sponsors of clinical trials can realistically partner with patients and how patients can partner with sponsors to meet the demands of:

    • Evolving Science: Personalized Medicine
    • Higher Quality Data
    • Lower Dropout Rates
    • New Therapies Faster to Market

     

    Patients as Partners takes a broad view of the patient experience and how we engage with patients across the entire clinical trial continuum. This includes early research, patient-centric protocol design, recruitment, retention, engagement, and communicating results with patients acting as ambassadors and educators.

    “If you put the patient lens in front, you start to come up with some really solid answers and solutions.” – Jeffrey Kasher, PhD, Eli Lilly

    The conference is designed for clinical trial executives in pharma and biotech, directors in patient advocacy and academia, and service providers who are looking to incorporate the patient perspective throughout the clinical trial process, valuing patients and treating them as partners, ultimately leading to more successful clinical trials. Take advantage of the first early bird and register by December 20th.

    Speaking Faculty:

    •     Annette Bar-Cohen, MA, MPH, Executive Director, Center for NBCC Advocacy Training

    National Breast Cancer Coalition

    •     Lily Cappelletti, Associate Director, Research Partnerships, The Michael J. Fox

    Foundation for Parkinson’s Research

    •     Lama Chahine, MD, Instructor of Neurology, Parkinson’s Disease and Movement

    Disorders Center,University of Pennsylvania

    •     Jacqueline Cole, Clinical Operations Portfolio Management, Oncology, Eli Lilly
    •     Maria Corvez, Clinical Research Manager II, Millennium Pharmaceuticals
    •     Iris Culbert, Senior Clinical Project Manager, Global Clinical Operations, Teva

    Pharmaceuticals

    •     Daniel Davis, Oncology Business Unit Advisor, Eli Lilly
    •     Victoria DiBiaso, Head of Investigator & Patient Networks, Sanofi Genzyme
    •     Adam Dole, Presidential Innovation Fellow, The White House*
    •     Ken Getz, MBA, Director of Sponsored Research / Founder, Tufts CSDD / CISCRP
    •     Stuart Horowitz, PhD, MBA, President, Global Professional Services, WIRB Copernicus

    Group

    •     Andreas Koester, MD, PhD, VP, Clinical Trial Innovation & External Alliances, Janssen
    •     Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer
    •     Debra Lounsbury, Principal Scientist, BioMarin
    •     Kimberly McCleary, Director, Strategic Initiatives, FasterCures
    •     Nariman Nasser,Digital Strategist, Genentech
    •     Bray Patrick-Lake, BS, MFS, Director of Stakeholder Engagement, Clinical Trials

    Transformation Initiative

    •     Christine Pierre, President, Society for Clinical Research Sites
    •     Tomasz Sablinski, MD, PhD, Founder & CEO, Transparency Life Sciences
    •     Jean Slutsky, PA, MSPH, Director, Center for Outcomes and Evidence Agency for

    Healthcare Research and Quality

    •     Komathi Stem, Senior Director, Product Development, Innovation Lead, Genentech
    •     Andrea Tan, Operations Research Analyst, Office of Strategic Programs, CDER, FDA
    •     Ronnie Todaro, Vice President, National Programs / Co-Chair, Parkinson’s Disease

    Foundation / CTTI Patient Leadership Council

    •     Jennifer Wulff, Director, Clinical Innovation, Pfizer*
    •     Anthony Yanni, Head of Patient Value & Strategy, Sanofi Genzyme

     

    *Invited speakers